SAA2 and AA amyloidosis: demonstrated the capacity of SAA1(1–5) to destabilize SAA fibrils, thereby placing the peptide as a promising lead drug for the treatment of amyloid A amyloidosis, a common secondary disease occurring within the context of uncontrolled inflammation (101).